BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baelum JK, Moe EE, Nybo M, Vinholt PJ. Venous Thromboembolism in Patients With Thrombocytopenia: Risk Factors, Treatment, and Outcome. Clin Appl Thromb Hemost 2017;23:345-50. [DOI: 10.1177/1076029615613158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Kim Y. Risk of thromboembolism in patients with multiple myeloma treated with daratumumab: a systemic review and meta-analysis. Int J Hematol 2020;112:650-7. [DOI: 10.1007/s12185-020-02954-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ture Z, Kalin-Unuvar G. A case of Crimean Congo hemorrhagic fever complicated with acute pulmonary embolism. J Med Virol 2021;93:3925-8. [PMID: 32716057 DOI: 10.1002/jmv.26358] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Wang C, Wu VC, Lee C, Kuo C, Chen Y, Chu P, Chen S, Wen M, See L, Chang S. Effectiveness and safety of non-vitamin-K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with thrombocytopenia. J Thromb Thrombolysis 2019;47:512-9. [DOI: 10.1007/s11239-018-1792-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
4 Alanazi F, Kwa FAA, Burchall G, Jackson DE. New generation drugs for treatment of multiple myeloma. Drug Discov Today 2020;25:367-79. [PMID: 31765717 DOI: 10.1016/j.drudis.2019.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]